Skip to main content
. Author manuscript; available in PMC: 2010 Sep 1.
Published in final edited form as: Int J Cancer. 2010 Sep 1;127(5):1052–1059. doi: 10.1002/ijc.25117

Figure 1.

Figure 1

Immunohistochemistry of human TGCT using anti-C2GnT-1. Normal testis (a) and teratoma of low-grade malignancy (b) were negative for anti-C2GnT-1. Embryonal carcinoma (c) and choriocarcinoma (d), which have high malignant potential, were strongly positive for anti-C2GnT-1. Scale bar: 10 µm.